Survival analysis revealed that high levels of FOXC1 indicated a worse prognosis in CRC patients, while high levels of HGF and IPO5 did not suggest a poor prognosis according to the TCGA cohort (Figs. 6B and S4A, B). Here, IPO5 is linked to colorectal carcinoma.